
SFARI is pleased to announce that it has awarded 27 grants (21 Pilot Awards and 6 Research Awards) in response to the 2016 Pilot and Research Awards request for applications.

SFARI is pleased to announce that it has awarded 27 grants (21 Pilot Awards and 6 Research Awards) in response to the 2016 Pilot and Research Awards request for applications.

This issue of the SFARI newsletter includes: (1) SPARK update, (2) Simons Simplex Collection: Updated medical and educational data now available, (3) SFARI Gene: New data available, (4) SFARI at IMFAR 2017, (5) Presentations by SFARI Investigators at IMFAR 2017, (6) Special Interest Group at IMFAR 2017: Promoting partnerships between patient advocacy groups and researchers to improve autism research, (7) A Conversation with SFARI Investigator Liqun Luo, (8) Highlights of SFARI-funded research, (9) Past lecture: Stephan Sanders, “What can genetics tell us about autism spectrum disorder?”, (10) Past lecture: Mark Zylka, “Exploiting genetics to identify environmental risks for autism”.

SFARI is pleased to announce that it has awarded five grants in response to the Whole-Genome Analysis for Autism Risk Variants request for applications. We are also announcing plans for the release of whole-genome sequencing data from the Simons Simplex Collection (SSC) for analysis by the entire research community.


Ben Philpot is a Kenan Distinguished Professor in the Neuroscience Center and Department of Cell Biology & Physiology at the University of North Carolina (UNC) at Chapel Hill.

On April 10, 2018, SFARI held a workshop to discuss online platforms for visualizing and analyzing SFARI genomics data. These platforms included the Genotypes and Phenotypes in Families web interface, created by SFARI Investigator Ivan Iossifov’s team, and Hub.iobio, which is currently being developed by Frameshift.

Peter Kind and colleagues show that brief treatment with lovastatin results in sustained correction of physiological and behavioral deficits in a rat model of fragile X syndrome.

In this blog post, the SFARI science team provides insight into SFARI’s scientific priorities. A number of experimental design issues to consider when preparing a grant application in response to the 2018 Pilot and Research Awards RFA are also discussed.

Sharmila Banerjee-Basu, founder and chief scientific officer at MindSpec Inc., discusses SFARI Gene and how it is changing the face of autism genetics research.

On 12 and 13 June, the Simons Foundation Autism Research Initiative (SFARI) held its second workshop on 16p11.2 deletion and duplication. A total of 62 participants from across the U.S. and Europe attended the meeting.